PCOS and Depression Linked to Higher Cardiometabolic Risk: Study
Researchers have found in a new study that Women with polycystic ovary syndrome (PCOS) who are also diagnosed with depression have a 56% higher likelihood of developing metabolic syndrome. Further, there is increased risk of type 2 diabetes and cardiovascular disease.
Therefore, it is recommended that clinicians screen all women with PCOS for mental health conditions to address potential health risks early.
Patients with polycystic ovary syndrome (PCOS) are at high risk of depression, anxiety, and metabolic syndrome (MetSyn), a key predictor of cardiovascular disease. The impact of depression and/or anxiety on MetSyn is unknown in this population. A study was done to compare the risk of developing MetSyn in patients with PCOS with and without a history of depression and/or anxiety.
Retrospective longitudinal cohort study (2008-2022) with median follow-up of 7 years at a tertiary care ambulatory practice. Patients with hyperandrogenic PCOS and at least 2 evaluations for MetSyn ≥3 years apart (n = 321) were included.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.